Cell-type specific interaction of endothelin and the nitric oxide system: Pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter- lacZ-transgenic mice

Journal of Physiology

Volumn 581, Issue 3, 2007, Pages 1173-1181

  Slowinski, Torsten ^a,b   Kalk, Philipp ^a,c   Christian, Maren ^a   Schmager, Fred ^d   Relle, Katharina ^a,c   Godes, Michael ^a,c   Funke Kaiser, Heiko ^a   Neumayer, Hans H ^b   Bauer, Christian ^e   Theuring, Franz ^a   Hocher, Berthold ^a  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berlin Institute of Health   (Germany)

^d BAYER PHARMA AG   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; BETA GALACTOSIDASE; ENDOTHELIN 1; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; FETUS DEVELOPMENT; IN VIVO STUDY; KIDNEY; KIDNEY CORTEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; STAINING; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; BRAIN REGION; CELLS BY BODY ANATOMY; CONTROLLED STUDY; EMBRYO; GENE SEQUENCE; GLOMERULAR CELL; KIDNEY CELL; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; LACZ GENE; MOLECULAR INTERACTION; PARTICLE SIZE; TISSUE SECTION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PRESSURE; CARTILAGE; ENDOTHELIN-1; ENZYME INHIBITORS; FACIAL BONES; HUMANS; KIDNEY; KIDNEY CORTEX; KIDNEY GLOMERULUS; KIDNEY TUBULES; LAC OPERON; MICE; MICE, TRANSGENIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENOTYPE; PROMOTER REGIONS (GENETICS); REPRODUCIBILITY OF RESULTS; SKULL;

EID: 34250019905     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.131201     Document Type: Article

References (49)

1. Aguzzi A & Theuring F (1994). Improved in situ β-galactosidase staining for histological analysis of transgenic mice. Histochemistry 102, 477-481.
2. Arai H, Hori S, Aramori I, Ohkubo H & Nakanishi S (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348, 730-732.
3. Boulanger C & Luscher TF (1990). Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85, 587-590.
4. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I & Busse R (2000). An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A 97, 9747-9752.
5. Clouthier DE, Hosoda K, Richardson JA, Williams SC, Yanagisawa H, Kuwaki T, Kumada M, Hammer RE & Yanagisawa M (1998). Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125, 813-824.
6. de Gasparo M, Catt KJ, Inagami T, Wright JW & Unger T (2000). International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52, 415-472.
7. Deng LY & Schiffrin EL (1998). Endothelin-1 gene expression in blood vessels and kidney of spontaneously hypertensive rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats. J Cardiovasc Pharmacol 31 (Suppl. 1), S380-S383.
8. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD & Vane JR (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85, 9797-9800.
9. Funke-Kaiser H, Orzechowski HD, Richter M & Paul M (1998). Human endothelin-converting enzyme-1 beta mRNA expression is regulated by an alternative promoter. J Cardiovasc Pharmacol 31 (Suppl. 1), S7-S9.
10. Funke-Kaiser H, Thomas A, Bremer J, Kovacevic SD, Scheuch K, Bolbrinker J, Theis S, Lemmer J, Zimmermann A, Zollmann FS, Herrmann SM, Paul M & Orzechowski HD (2003). Regulation of the major isoform of human endothelin-converting enzyme-1 by a strong housekeeping promoter modulated by polymorphic microsatellites. J Hypertens 21, 2111-2124.
11. Garcia NH, Plato CF, Stoos BA & Garvin JL (1999). Nitric oxide-induced inhibition of transport by thick ascending limbs from Dahl salt-sensitive rats. Hypertension 34, 508-513.
12. Gariepy CE, Ohuchi T, Williams SC, Richardson JA & Yanagisawa M (2000). Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105, 925-933.
13. Giannessi D, Del Ry S & Vitale RL (2001). The role of endothelins and their receptors in heart failure. Pharmacol Res 43, 111-126.
14. Haynes WG, Strachan FE & Webb DJ (1995). Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92, 357-363.
15. + -transporting epithelia. Am J Physiol Cell Physiol 289, C717-C726.
16. Hocher B, Dembowski C, Slowinski T, Friese ST, Schwarz A, Siren AL, Neumayer HH, Thone-Reineke C, Bauer C, Nafz B & Ehrenreich H (2001). Impaired sodium excretion, decreased glomerular filtration rate and elevated blood pressure in endothelin receptor type B deficient rats. J Mol Med 78, 633-641.
17. Hocher B, Kalk P, Slowinski T, Godes M, Mach A, Herzfeld S, Wiesner D, Arck PC, Neumayer HH & Nafz B (2003). ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease. J Am Soc Nephrol 14, 367-376.
18. Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD & Theuring F (1997). Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99, 1380-1389.
19. Hocher B, Zart R, Schwarz A, Vogt V, Braun C, Thone-Reineke C, Braun N, Neumayer HH, Koppenhagen K, Bauer C & Rohmeiss P (1998). Renal endothelin system in polycystic kidney disease. J Am Soc Nephrol 9, 1169-1177.
20. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M & Masaki T (1989). The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem 264, 14954-14959.
21. Kahler J, Mendel S, Weckmuller J, Orzechowski HD, Mittmann C, Koster R, Paul M, Meinertz T & Munzel T (2000). Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol 32, 1429-1437.
22. Kaminski A, Kasch C, Zhang L, Kumar S, Sponholz C, Choi YH, Ma N, Liebold A, Ladilov Y, Steinhoff G & Stamm C (2006). Endothelial nitric oxide synthase mediates protective effects of hypoxic preconditioning in lungs. Respir Physiol Neurobiol 155, 280-285.
23. Kawana M, Lee ME, Quertermous EE & Quertermous T (1995). Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol Cell Biol 15, 4225-4231.
24. Kohan DE (1997). Endothelins in the normal and diseased kidney. Am J Kidney Dis 29, 2-26.
25. Kurihara Y, Kurihara H, Oda H, Maemura K, Nagai R, Ishikawa T & Yazaki Y (1995). Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest 96, 293-300.
26. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH & Kamada N (1994). Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368, 703-710.
27. Lahera V, Navarro J, Biondi ML, Ruilope LM & Romero JC (1993). Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am J Physiol Renal Physiol 264, F344-F347.
28. Lee ME, Bloch KD, Clifford JA & Quertermous T (1990). Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence. J Biol Chem 265, 10446-10450.
29. Lee ME, Dhadly MS, Temizer DH, Clifford JA, Yoshizumi M & Quertermous T (1991). Regulation of endothelin-1 gene expression by Fos and Jun. J Biol Chem 266, 19034-19039.
30. Lee YJ, Shin SJ & Tsai JH (1994). Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 17, 263-266.
31. Mattson DL & Wu F (2000). Control of arterial blood pressure and renal sodium excretion by nitric oxide synthase in the renal medulla. Acta Physiol Scand 168, 149-154.
32. Minchenko AG, Stevens MJ, White L, Abatan OI, Komjati K, Pacher P, Szabo C & Obrosova IG (2003). Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly (ADP-ribose) polymerase activation. FASEB J 17, 1514-1516.
33. Miyauchi T & Masaki T (1999). Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61, 391-415.
34. Moridaira K, Nodera M, Sato G & Yanagisawa H (2003). Detection of prepro-ET-1 mRNA in normal rat kidney by in situ RT-PCR. Nephron Exp Nephrol 95, e55-e61.
35. Pfab T, Thone-Reineke C, Theilig F, Lange I, Witt H, Maser-Gluth C, Bader M, Stasch JP, Ruiz P, Bachmann S, Yanagisawa M & Hocher B (2006). Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure. J Am Soc Nephrol 17, 1082-1089.
36. Quaschning T, Voss F, Relle K, Kalk P, Vignon-Zellweger N, Pfab T, Bauer C, Theilig F, Bachmann S, Kraemer-Guth A, Wanner C, Theuring F, Galle J & Hocher B (2007). Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: Lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice. J Am Soc Nephrol 18, 730-740.
37. Reimunde FM, Castanares C, Redondo-Horcajo M, Lamas S & Rodriguez-Pascual F (2005). Endothelin-1 expression is strongly repressed by AU-rich elements in the 3′-untranslated region of the gene. Biochem J 387, 763-772.
38. Reiterova J, Merta M, Stekrova J, Cabartova Z, Cibulka R, Maixnerova D, Rysava R, Rihova Z, Tesar V & Motan J (2006). Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease. Kidney Blood Press Res 29, 182-188.
39. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K & Masaki T (1990). Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348, 732-735.
40. Serneri GG, Modesti PA, Cecioni I, Biagini D, Migliorini A, Costoli A, Colella A, Naldoni A & Paoletti P (1995). Plasma endothelin and renal endothelin are two distinct systems involved in volume homeostasis. Am J Physiol Heart Circ Physiol 268, H1829-H1837.
41. Stoos BA, Carretero OA & Garvin JL (1994). Endothelial-derived nitric oxide inhibits sodium transport by affecting apical membrane channels in cultured collecting duct cells. J Am Soc Nephrol 4, 1855-1860.
42. Stoos BA, Garcia NH & Garvin JL (1995). Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 6, 89-94.
43. Sventek P, Turgeon A, Garcia R & Schiffrin EL (1996). Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension. J Hypertens 14, 57-64.
44. Theuring F, Gotz W, Balling R, Korf HW, Schulze F, Herken R & Gruss P (1990). Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen. Oncogene 5, 225-232.
45. Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C & Michel JB (1999). A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur J Biochem 264, 341-349.
46. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N & Schwab SJ (2000). Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57, 1675-1680.
47. +-stimulated endothelin secretion. Am J Kidney Dis 35, LII-LIV.
48. Yin JJ, Mohammad KS, Kakonen SM, Harris S, Wu-Wong JR, Wessale JL, Padley RJ, Garrett IR, Chirgwin JM & Guise TA (2003). A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci U S A 100, 10954-10959.
49. Yokokawa K, Kohno M, Murakawa K, Yasunari K, Horio T, Inoue T & Takeda T (1989). Acute effects of endothelin on renal hemodynamics and blood pressure in anesthetized rats. Am J Hypertens 2, 715-717.